Advancing Nanomedicine: For Bone Defect Repair and Regeneration
Niu Z., Fan Y., Yin L., Tong Y., Yao L., Ding S.
Narrative Review, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Int J Nanomedicine (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41424455
- PMCID
- PMC12717955
- DOI
- 10.2147/ijn.s545353
Abstract (original English)
The clinical significance of bone defects is not well understood; these pathological conditions not only compromise patients' quality of life but may also result in permanent functional impairment if inadequately addressed. Consequently, the development of effective therapeutic interventions for bone defect repair and regeneration is a critical medical challenge. Recent advancements in nanotechnology, particularly engineered nanoparticle systems, have introduced promising new strategies for bone tissue regeneration. However, it is important to note that most nanoparticle-based approaches remain at the preclinical or experimental stage, and their clinical translation is still limited. These sophisticated nanomaterials enhance critical biological processes including osteoconduction, osteoinduction, and osteogenesis which collectively facilitate optimal bone healing. Notably, certain nanoparticles possess intrinsic properties that enable modulation of the inflammatory microenvironment and immunological responses during bone repair. Furthermore, the integration of nanoparticles with complementary biomaterials yielded composite systems with superior therapeutic efficacy in addressing complex bone defects. This comprehensive review summarizes the pathophysiological mechanisms underlying bone repair, systematically examines the preclinical and experimental therapeutic applications of
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.